Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by TAKAVARASHA, L.
Right arrow Articles by CONSTABLE, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAKAVARASHA, L.
Right arrow Articles by CONSTABLE, T. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1982 British Society for Rheumatology


research-article

A PHARMACIST’S AUDIT OF ANTIRHEUMATIC DRUGS

L. TAKAVARASHA1, D. L. SCOTT2, and T. J. CONSTABLE3

1Selly Oak Hospital Birmingham B29 6JD
2Department of INvestigative Pathology, Rheumatism Research Wing, University of Birminghma Birmingham B15 2TJ
3Walsall Manor Hospital Walsall

Correspondence to: Requests for reprints to Dr. D.L.Scott

The results of an audit, by a hospital pharmacist, of antirheumatic drug use at four rheumatology units are presented. Profiles can be developed for each drug which indicate their efficacy and the adverse reaction rate in clinical practice. These can be used to make rational therapeutic choices. A pharmacist can effectively collate such data to provide an unbiased information source.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.